Both in Pharmaceuticals
InMed Pharmaceuticals vs iBio
Over the past year INM returned +405.8% and IBIO returned −47.7%; their daily moves had a correlation of 0.03.
INM +405.8% IBIO −47.7%Growth of $1, one year, split-adjusted
| Metric | INM | IBIO |
|---|---|---|
| Price | $8.75 | $0.8000 |
| Market cap | $48.1M | $51.4M |
| Today | +420.83% | −2.85% |
| 1 month | +557.9% | −23.8% |
| 6 months | +1104.6% | −54.8% |
| Year to date | +725.5% | −58.5% |
| 1 year | +373.0% | −54.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 24.8× | 514.5× |
| Net cash | $2.2M | $88.0M |
| Dividend yield | — | — |
| Volatility (60d) | 338.3% | 65.6% |
| Short % of float | 0.1% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).